Suppr超能文献

细胞的抗病毒状态:来自 SARS-CoV-2 的启示。

The antiviral state of the cell: lessons from SARS-CoV-2.

机构信息

The Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.

The Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.

出版信息

Curr Opin Immunol. 2024 Apr;87:102426. doi: 10.1016/j.coi.2024.102426. Epub 2024 May 24.

Abstract

In this review, we provide an overview of the intricate host-virus interactions that have emerged from the study of SARS-CoV-2 infection. We focus on the antiviral mechanisms of interferon-stimulated genes (ISGs) and their modulation of viral entry, replication, and release. We explore the role of a selection ISGs, including BST2, CD74, CH25H, DAXX, IFI6, IFITM1-3, LY6E, NCOA7, PLSCR1, OAS1, RTP4, and ZC3HAV1/ZAP, in restricting SARS-CoV-2 infection and discuss the virus's countermeasures. By synthesizing the latest research on SARS-CoV-2 and host antiviral responses, this review aims to provide a deeper understanding of the antiviral state of the cell under SARS-CoV-2 and other viral infections, offering insights for the development of novel antiviral strategies and therapeutics.

摘要

在这篇综述中,我们概述了从 SARS-CoV-2 感染研究中出现的复杂的宿主-病毒相互作用。我们专注于干扰素刺激基因 (ISGs) 的抗病毒机制及其对病毒进入、复制和释放的调节。我们探讨了一系列 ISGs 的作用,包括 BST2、CD74、CH25H、DAXX、IFI6、IFITM1-3、LY6E、NCOA7、PLSCR1、OAS1、RTP4 和 ZC3HAV1/ZAP,它们在限制 SARS-CoV-2 感染中的作用,并讨论了病毒的对策。通过综合 SARS-CoV-2 和宿主抗病毒反应的最新研究,本综述旨在更深入地了解 SARS-CoV-2 和其他病毒感染下细胞的抗病毒状态,为开发新型抗病毒策略和疗法提供思路。

相似文献

1
The antiviral state of the cell: lessons from SARS-CoV-2.
Curr Opin Immunol. 2024 Apr;87:102426. doi: 10.1016/j.coi.2024.102426. Epub 2024 May 24.
2
PLSCR1 suppresses SARS-CoV-2 infection by downregulating cell surface ACE2.
J Virol. 2025 Mar 18;99(3):e0208524. doi: 10.1128/jvi.02085-24. Epub 2025 Feb 13.
3
Functional landscape of SARS-CoV-2 cellular restriction.
Mol Cell. 2021 Jun 17;81(12):2656-2668.e8. doi: 10.1016/j.molcel.2021.04.008. Epub 2021 Apr 13.
4
Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
PLoS Biol. 2021 Dec 21;19(12):e3001065. doi: 10.1371/journal.pbio.3001065. eCollection 2021 Dec.
5
Anti-interferon armamentarium of human coronaviruses.
Cell Mol Life Sci. 2025 Mar 13;82(1):116. doi: 10.1007/s00018-025-05605-z.
7
8
Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4).
mBio. 2023 Aug 31;14(4):e0109023. doi: 10.1128/mbio.01090-23. Epub 2023 Jun 29.
9
Interferon-stimulated genes and their antiviral activity against SARS-CoV-2.
mBio. 2024 Sep 11;15(9):e0210024. doi: 10.1128/mbio.02100-24. Epub 2024 Aug 22.
10
Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infection.
J Virol. 2024 Sep 17;98(9):e0090524. doi: 10.1128/jvi.00905-24. Epub 2024 Aug 29.

引用本文的文献

1
Interferons in health and disease.
Cell. 2025 Aug 21;188(17):4480-4504. doi: 10.1016/j.cell.2025.06.044.
2
Evolution of antiviral host defenses against a backdrop of endogenous retroelements.
Science. 2025 Aug 7;389(6760):588-593. doi: 10.1126/science.adx4379.
3
CD317 functions as a key antiviral factor in human herpesvirus 6 (HHV-6) infection.
J Virol. 2025 Jul 22;99(7):e0084125. doi: 10.1128/jvi.00841-25. Epub 2025 Jun 24.

本文引用的文献

1
Tetherin Restricts SARS-CoV-2 despite the Presence of Multiple Viral Antagonists.
Viruses. 2023 Nov 30;15(12):2364. doi: 10.3390/v15122364.
2
Resurrection of 2'-5'-oligoadenylate synthetase 1 (OAS1) from the ancestor of modern horseshoe bats blocks SARS-CoV-2 replication.
PLoS Biol. 2023 Nov 28;21(11):e3002398. doi: 10.1371/journal.pbio.3002398. eCollection 2023 Nov.
4
Tetherin antagonism by SARS-CoV-2 ORF3a and spike protein enhances virus release.
EMBO Rep. 2023 Dec 6;24(12):e57224. doi: 10.15252/embr.202357224. Epub 2023 Oct 11.
5
Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.
Cell Host Microbe. 2023 Oct 11;31(10):1668-1684.e12. doi: 10.1016/j.chom.2023.08.003. Epub 2023 Sep 21.
6
SARS-CoV-2 variants evolve convergent strategies to remodel the host response.
Cell. 2023 Oct 12;186(21):4597-4614.e26. doi: 10.1016/j.cell.2023.08.026. Epub 2023 Sep 21.
7
LY6E is a pan-coronavirus restriction factor in the respiratory tract.
Nat Microbiol. 2023 Aug;8(8):1587-1599. doi: 10.1038/s41564-023-01431-w. Epub 2023 Jul 13.
8
PLSCR1 is a cell-autonomous defence factor against SARS-CoV-2 infection.
Nature. 2023 Jul;619(7971):819-827. doi: 10.1038/s41586-023-06322-y. Epub 2023 Jul 12.
9
Innate immunity and interferon in SARS-CoV-2 infection outcome.
Immunity. 2023 Jul 11;56(7):1443-1450. doi: 10.1016/j.immuni.2023.06.018.
10
Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4).
mBio. 2023 Aug 31;14(4):e0109023. doi: 10.1128/mbio.01090-23. Epub 2023 Jun 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验